{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:12:14Z","timestamp":1771362734636,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003186.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T00:00:00Z","timestamp":1323216000000}}],"reference-count":97,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003186.pub3","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T20:46:21Z","timestamp":1323117981000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Antiplatelet agents and anticoagulants for hypertension"],"prefix":"10.1002","author":[{"given":"Gregory YH","family":"Lip","sequence":"first","affiliation":[{"name":"University of Birmingham Centre for Cardiovascular Sciences, City Hospital; Dudley Road Birmingham UK B18 7QH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk C","family":"Felmeden","sequence":"additional","affiliation":[{"name":"City Hospital; University of Birmingham Centre for Cardiovascular Sciences; Birmingham UK B18 7QH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Dwivedi","sequence":"additional","affiliation":[{"name":"City Hospital; University of Birmingham Centre for Cardiovascular Sciences; Birmingham UK B18 7QH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,12,7]]},"reference":[{"issue":"9038","key":"10.1002\/14651858.CD003186.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"9118","key":"10.1002\/14651858.CD003186.pub3-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1161\/01.CIR.103.25.3069","article-title":"Aspirin, warfarin or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery","volume":"103","author":"Huynh","year":"2001","journal-title":"Circulation"},{"issue":"7252","key":"10.1002\/14651858.CD003186.pub3-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.321.7252.13","article-title":"Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial","volume":"321","author":"Meade","year":"2000","journal-title":"BMJ"},{"issue":"9098","key":"10.1002\/14651858.CD003186.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk","volume":"351","author":"The Medical Research Council's General Practice Research Framework","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003186.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.CIR.102.5.500","article-title":"Alcohol consumption and risk of coronary heart disease by diabetes status","volume":"102","author":"Ajani","year":"2000","journal-title":"Circulation"},{"issue":"6921","key":"10.1002\/14651858.CD003186.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003186.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1067\/mhj.2000.108239","article-title":"Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators","volume":"140","author":"Bhatt","year":"2000","journal-title":"Am.Heart J."},{"issue":"3","key":"10.1002\/14651858.CD003186.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.103.3.363","article-title":"Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery","volume":"103","author":"Bhatt","year":"2001","journal-title":"Circulation"},{"issue":"19","key":"10.1002\/14651858.CD003186.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/01.CIR.101.19.2231","article-title":"Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial","volume":"101","author":"Califf","year":"2000","journal-title":"Circulation"},{"issue":"9","key":"10.1002\/14651858.CD003186.pub3-BIB0011|cit11","first-page":"1720","article-title":"Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy","volume":"10","author":"Caravaca","year":"1995","journal-title":"Nephrol.Dial.Transplant."},{"issue":"5","key":"10.1002\/14651858.CD003186.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9149(01)01735-0","article-title":"Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Infarction Study (CARS)","volume":"88","author":"O'Connor","year":"2001","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1002\/14651858.CD003186.pub3-BIB0013|cit13","first-page":"1137","article-title":"Comparative effects of nabumetone, sulindac, and ibuprofen on renal function","volume":"24","author":"Cook","year":"1997","journal-title":"J Rheumatol."},{"issue":"3","key":"10.1002\/14651858.CD003186.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/08037059209077512","article-title":"Effect of ketoprofen on blood pressure, endocrine and renal responses to chronic dosing with captopril in patients with essential hypertension","volume":"1","author":"Cusson","year":"1992","journal-title":"Blood Press"},{"issue":"5","key":"10.1002\/14651858.CD003186.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1972.03210050013003","article-title":"Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction","volume":"222","author":"Drapkin","year":"1972","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/hj.1999.v137.92521","article-title":"Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators","volume":"137","author":"Thel","year":"1999","journal-title":"Am Heart J"},{"issue":"19","key":"10.1002\/14651858.CD003186.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1161\/01.CIR.97.19.1912","article-title":"Diabetes mellitus, glycoprotein IIb\/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators","volume":"97","author":"Kleiman","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0049-3848(98)00099-1","article-title":"Secondary stroke prevention with low-dose Aspirin, sustained release Dipyridamol alone and in combination","volume":"92","author":"Forbes CD for the ESPS Investigators","year":"1998","journal-title":"Thromb Res"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD003186.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.HYP.21.6.875","article-title":"Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension","volume":"21","author":"Ferri","year":"1993","journal-title":"Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD003186.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000204871","article-title":"Ticlopidine lowers plasma fibrinogen in patients with polycythaemia rubra vera and additional thrombotic risk factors. A double-blind controlled study","volume":"85","author":"Finelli","year":"1991","journal-title":"Acta Haematol."},{"issue":"1","key":"10.1002\/14651858.CD003186.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1067\/mhj.2001.111262","article-title":"Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo","volume":"141","author":"Fisher","year":"2001","journal-title":"Am.Heart J."},{"key":"10.1002\/14651858.CD003186.pub3-BIB0022|cit22","first-page":"55","article-title":"Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist","volume":"25","author":"Forbes","year":"1999","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/j.1875-9114.1993.tb02699.x","article-title":"Renovascular effects of nonprescription ibuprofen in elderly hypertensive patients with mild renal impairment","volume":"13","author":"Furey","year":"1993","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"M74","DOI":"10.1093\/gerona\/51A.2.M74","article-title":"The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons","volume":"51","author":"Gurwitz","year":"1996","journal-title":"J Gerontol.A Biol.Sci Med Sci"},{"issue":"4","key":"10.1002\/14651858.CD003186.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00002018-199921040-00007","article-title":"Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events","volume":"21","author":"Harker","year":"1999","journal-title":"Drug Saf"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0002-9149(96)00598-X","article-title":"Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia","volume":"78","author":"Harpaz","year":"1996","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1002\/14651858.CD003186.pub3-BIB0027|cit27","first-page":"494","article-title":"Study on the possible interaction between tenoxicam and atenolol in hypertensive patients","volume":"45","author":"Hartmann","year":"1995","journal-title":"Arzneimittelforschung."},{"issue":"5","key":"10.1002\/14651858.CD003186.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/08037059509077612","article-title":"Effect of indomethacin on blood pressure control during treatment with nitrendipine","volume":"4","author":"Harvey","year":"1995","journal-title":"Blood Press"},{"issue":"6","key":"10.1002\/14651858.CD003186.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/07420529709001452","article-title":"Influence of Aspirin usage on blood pressure: dose and administration-time dependencies","volume":"14","author":"Hermida","year":"1997","journal-title":"Chronobiology International"},{"issue":"1","key":"10.1002\/14651858.CD003186.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000115765","article-title":"Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants","volume":"24","author":"Herskovits","year":"1985","journal-title":"Eur Neurol."},{"issue":"8426","key":"10.1002\/14651858.CD003186.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(85)91144-4","article-title":"Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial","volume":"1","author":"Hess","year":"1985","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD003186.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archinte.1995.00430100075009","article-title":"The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil","volume":"155","author":"Houston","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0033|cit33","first-page":"219","article-title":"The influence of ticlopidine on the natural course of retinal vein occlusion","volume":"15","author":"Houtsmuller","year":"1984","journal-title":"Agents and Actions Supplements"},{"issue":"4","key":"10.1002\/14651858.CD003186.pub3-BIB0034|cit34","first-page":"257","article-title":"Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-1","volume":"10","author":"Johnson","year":"1996","journal-title":"J Hum.Hypertens"},{"issue":"10","key":"10.1002\/14651858.CD003186.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/j.1552-4604.1993.tb01932.x","article-title":"Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide","volume":"33","author":"Klassen","year":"1993","journal-title":"J Clin Pharmacol."},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0895-7061(94)00164-7","article-title":"Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine","volume":"8","author":"Klassen","year":"1995","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1002\/14651858.CD003186.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.STR.30.1.1","article-title":"Exercise and risk of stroke in male physicians","volume":"30","author":"Lee","year":"1999","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD003186.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.36.5.705","article-title":"Controlled trial of aspirin in cerebral ischemia: an addendum","volume":"36","author":"Lemak","year":"1986","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003186.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1097\/00004872-199112000-00105","article-title":"Indomethacin raises blood pressure in untreated essential hypertensives: a double-blind randomly allocated study versus placebo","volume":"9","author":"Magagna","year":"1991","journal-title":"J Hypertens Suppl"},{"issue":"4","key":"10.1002\/14651858.CD003186.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/08037059409102263","article-title":"Hemodynamic and humoral effects of low-dose aspirin in treated and untreated essential hypertensive patients","volume":"3","author":"Magagna","year":"1994","journal-title":"Blood Press"},{"issue":"1","key":"10.1002\/14651858.CD003186.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199207023270101","article-title":"The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group","volume":"327","author":"Maggioni","year":"1992","journal-title":"N.Engl.J Med"},{"issue":"9281","key":"10.1002\/14651858.CD003186.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003186.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1445-5994.1982.tb03826.x","article-title":"Non-steroidal anti-inflammatory drugs and blood pressure","volume":"12","author":"Mills","year":"1982","journal-title":"Aust.N.Z J Med"},{"issue":"4","key":"10.1002\/14651858.CD003186.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2125.1990.tb03809.x","article-title":"Effects of non-steroidal anti-inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension","volume":"30","author":"Minuz","year":"1990","journal-title":"Br.J.Clin.Pharmacol."},{"issue":"1","key":"10.1002\/14651858.CD003186.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2125.1995.tb04408.x","article-title":"Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition","volume":"39","author":"Minuz","year":"1995","journal-title":"Br.J Clin Pharmacol."},{"key":"10.1002\/14651858.CD003186.pub3-BIB0046|cit46","first-page":"S338","article-title":"Interaction of indomethacin with felodipine and enalapril","volume":"11 Suppl 5","author":"Morgan","year":"1993","journal-title":"J Hypertens Suppl"},{"issue":"11","key":"10.1002\/14651858.CD003186.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0895-7061(00)01204-8","article-title":"Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril","volume":"13","author":"Morgan","year":"2000","journal-title":"Am J Hypertens"},{"issue":"8 Pt 1","key":"10.1002\/14651858.CD003186.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0895-7061(99)00037-0","article-title":"Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan","volume":"12","author":"Nawarskas","year":"1999","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0049|cit49","first-page":"169","article-title":"Effects of captopril and ticlopidine, alone or in combination, in hypertensive patients with intermittent claudication","volume":"15","author":"Novo","year":"1996","journal-title":"Int Angiol."},{"issue":"10","key":"10.1002\/14651858.CD003186.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0002-9149(98)00153-2","article-title":"Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction","volume":"81","author":"Oosterga","year":"1998","journal-title":"Am.J.Cardiol."},{"issue":"3","key":"10.1002\/14651858.CD003186.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0952-3278(96)90020-4","article-title":"Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients","volume":"54","author":"Pancera","year":"1996","journal-title":"Prostaglandins Leukot.Essent.Fatty Acids"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomised trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD003186.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the Aspirin component of the ongoing Physicians' Health Study","volume":"321","author":"Steering Committee of the Physicians' Health Study Research Group","year":"1989","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1002\/14651858.CD003186.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00004872-199508000-00014","article-title":"Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients","volume":"13","author":"Polonia","year":"1995","journal-title":"J Hypertens"},{"issue":"6","key":"10.1002\/14651858.CD003186.pub3-BIB0055|cit55","first-page":"485-92, 460","article-title":"[Reduction of the antihypertensive effects of enalapril by indomethacin. Its independence from renal sodium retention]","volume":"15","author":"Polonia","year":"1996","journal-title":"Rev Port.Cardiol"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)03539-X","article-title":"Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice","volume":"357","author":"Collaborative Group of the Primary Prevention Project","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2125.1997.00632.x","article-title":"Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?","volume":"44","author":"Pritchard","year":"1997","journal-title":"Br.J Clin Pharmacol."},{"issue":"8","key":"10.1002\/14651858.CD003186.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/1529-0131(200008)43:8<1809::AID-ANR17>3.0.CO;2-D","article-title":"Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone","volume":"43","author":"Proudman","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005344-199808000-00017","article-title":"Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke","volume":"32","author":"Puranen","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"issue":"18","key":"10.1002\/14651858.CD003186.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1161\/01.CIR.99.18.2371","article-title":"Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb\/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb\/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators","volume":"99","author":"Mahaffey","year":"1999","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.STR.32.2.399","article-title":"Use of aspirin, epistaxis and untreated hypertension as risk factors for primary intracerebral hemorrhage in middle-aged and elderly people","volume":"32","author":"Saloheimo","year":"2001","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD003186.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.86.5.1407","article-title":"Randomized trial of thrombolysis versus heparin in unstable angina","volume":"86","author":"Schreiber","year":"1992","journal-title":"Circulation"},{"issue":"8","key":"10.1002\/14651858.CD003186.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/S0735-1097(01)01285-2","article-title":"Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen","volume":"37","author":"Schuhlen","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1002\/14651858.CD003186.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archneur.1993.00540070030010","article-title":"Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event","volume":"50","author":"Sivenius","year":"1993","journal-title":"Arch Neurol."},{"issue":"5","key":"10.1002\/14651858.CD003186.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1681\/ASN.V451133","article-title":"Effect of low-dose aspirin on thromboxane production and the antihypertensive effect of captopril","volume":"4","author":"Smith","year":"1993","journal-title":"J Am Soc.Nephrol."},{"issue":"6","key":"10.1002\/14651858.CD003186.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.410420606","article-title":"A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) study group.","volume":"42","author":"SPIRIT","year":"1997","journal-title":"Ann Neurol."},{"issue":"8","key":"10.1002\/14651858.CD003186.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00004872-199408000-00009","article-title":"Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans","volume":"12","author":"Sturrock","year":"1994","journal-title":"J Hypertens"},{"issue":"3","key":"10.1002\/14651858.CD003186.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1620\/tjem.165.201","article-title":"No adverse effect of non-steroidal anti-inflammatory drugs, sulindac and diclofenac sodium, on blood pressure control with a calcium antagonist, nifedipine, in elderly hypertensive patients","volume":"165","author":"Takeuchi","year":"1991","journal-title":"Tohoku J Exp.Med"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med"},{"issue":"9 Pt 1","key":"10.1002\/14651858.CD003186.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(99)00075-8","article-title":"Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs","volume":"12","author":"Thakur","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0071|cit71","first-page":"57","article-title":"Treatment of hypertension with dihydropyridine calcium antagonists and aspirin","volume":"1","author":"Tison","year":"1994","journal-title":"Blood Press Suppl"},{"issue":"8","key":"10.1002\/14651858.CD003186.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00004872-200018080-00014","article-title":"Different patterns of renal prostaglandins I2 and E2 in patients with essential hypertension with low to normal or high renin activity","volume":"18","author":"Tsuji","year":"2000","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results","volume":"54","author":"UK-TIA study group","year":"1991","journal-title":"J Neurol Neurosurg Psych"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01478209","article-title":"Does chronic Aspirin treatment increase blood pressure in man?","volume":"59","author":"Walter","year":"1981","journal-title":"Klin Wochenschr"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00045391-200103000-00003","article-title":"Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients","volume":"8","author":"Whelton","year":"2001","journal-title":"Am J Ther."},{"issue":"3","key":"10.1002\/14651858.CD003186.pub3-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006186.pub2","article-title":"Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks","author":"Aguilar","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8693","key":"10.1002\/14651858.CD003186.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"issue":"8692","key":"10.1002\/14651858.CD003186.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","article-title":"Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/oxfordjournals.bmb.a072892","article-title":"Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease","volume":"50","author":"Collins","year":"1994","journal-title":"Br Med Bull"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S0266462300009557","article-title":"Introduction: the quality of the medical evidence: is it good enough?","volume":"12","author":"Dickersin","year":"1996","journal-title":"Int J Technol Assess Health Care"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004659.pub2","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"18","key":"10.1002\/14651858.CD003186.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM200005043421803","article-title":"Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events","volume":"342","author":"O'Neill","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0084|cit84","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.jhh.1000556","article-title":"The role of rheological and haemostatic factors in hypertension","volume":"11","author":"Lee","year":"1997","journal-title":"J Hum Hypertens"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0086|cit86","unstructured":"Lefebvre C McDonald S Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE Paper presented at the Fourth International Cochrane Colloquium, 20-24 Oct 1996; Adelaide, Australia 1996"},{"issue":"9","key":"10.1002\/14651858.CD003186.pub3-BIB0087|cit87","first-page":"693","article-title":"Abnormalities of rheology and coagulation in hypertension","volume":"8","author":"Lip","year":"1994","journal-title":"J Hum Hypertens"},{"issue":"12","key":"10.1002\/14651858.CD003186.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/S0002-9149(97)00749-2","article-title":"Relationship of endothelium, thrombogenesis, and haemorrheology in systemic hypertension to ethnicity and left ventricular hypertrophy","volume":"80","author":"Lip","year":"1997","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1002\/14651858.CD003186.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.CIR.101.3.218","article-title":"Does hypertension confer a prothrombotic state? Virchow's triad revisited","volume":"101","author":"Lip","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003333","article-title":"Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm","author":"Lip","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2796.2001.00800.x","article-title":"Should patients with hypertension receive antithrombotic therapy?","volume":"249","author":"Lip","year":"2001","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD003186.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Prospective Studies Collaboration","year":"2002","journal-title":"Lancet"},{"issue":"8899","key":"10.1002\/14651858.CD003186.pub3-BIB0093|cit93","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study","volume":"343","author":"SPAF II Study","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003186.pub3-BIB0094|cit94","first-page":"S83","article-title":"Endothelial dysfunction in hypertension","volume":"14","author":"Vanhoutte","year":"1996","journal-title":"J Hypertens Suppl"},{"issue":"9","key":"10.1002\/14651858.CD003186.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00004872-199309000-00004","article-title":"1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization\/International Society of Hypertension meeting","volume":"11","author":"WHO Guidelines Sub-Committee","year":"1993","journal-title":"J Hypertens"},{"issue":"2","key":"10.1002\/14651858.CD003186.pub3-BIB0096|cit96","first-page":"151","article-title":"1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee","volume":"17","author":"WHO","year":"1999","journal-title":"J Hypertens"},{"issue":"7445","key":"10.1002\/14651858.CD003186.pub3-BIB0097|cit97","first-page":"926","article-title":"British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary","volume":"328","author":"Williams","year":"2004","journal-title":"BMJ"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003186.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003186.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T09:52:34Z","timestamp":1713174754000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003186.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,7]]},"references-count":97,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003186.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD003186.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,7]]}}}